KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilysys (AGYS) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Agilysys (AGYS) over the last 16 years, with Q4 2025 value amounting to $81.5 million.

  • Agilysys' Cash & Equivalents rose 3405.47% to $81.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $81.5 million, marking a year-over-year increase of 3405.47%. This contributed to the annual value of $73.0 million for FY2025, which is 4958.9% down from last year.
  • Per Agilysys' latest filing, its Cash & Equivalents stood at $81.5 million for Q4 2025, which was up 3405.47% from $59.3 million recorded in Q3 2025.
  • Agilysys' 5-year Cash & Equivalents high stood at $144.9 million for Q1 2024, and its period low was $54.9 million during Q3 2024.
  • For the 5-year period, Agilysys' Cash & Equivalents averaged around $96.8 million, with its median value being $101.5 million (2021).
  • Per our database at Business Quant, Agilysys' Cash & Equivalents soared by 11259.08% in 2021 and then plummeted by 6144.36% in 2025.
  • Over the past 5 years, Agilysys' Cash & Equivalents (Quarter) stood at $115.1 million in 2021, then dropped by 8.08% to $105.8 million in 2022, then grew by 9.81% to $116.2 million in 2023, then crashed by 47.71% to $60.8 million in 2024, then surged by 34.05% to $81.5 million in 2025.
  • Its Cash & Equivalents stands at $81.5 million for Q4 2025, versus $59.3 million for Q3 2025 and $55.6 million for Q2 2025.